Scleromitrion diffusum

Ethnobotanical Studies

Studies

Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang inhibits the progression of triple negative breast cancer though the activation inhibition of NF-κB triggered by CAFs-derived IL6.

Summary

Researchers studied the herb pair Scutellaria barbata and Scleromitrion diffusum for their anti-tumor effects on triple-negative breast cancer. Understanding their molecular mechanisms can lead to new treatment options.

Pan Y et al (2024).
J Ethnopharmacol.
PubMed:
39121924

Exploring the mechanism of Scleromitrion diffusum (Willd.) in treating lung cancer based on network pharmacology and experimental validation.

Summary

SDW components target 88 genes in lung cancer treatment, inhibiting cell proliferation via P I3K/Akt and MEK/ERK pathways. SDW may regulate apoptosis and proliferation in lung cancer therapy. Valuable insights into molecular mechanisms provided through network pharmacology, molecular docking, and experimental validation.

Huang S et al (2024).
Nat Prod Res.
PubMed:
38885333

Comparative study of Scleromitrion diffusum and Oldenlandia corymbosa: Microscopy, TLC, HPLC, and antioxidant activity.

Ho YL et al (2024).
Microsc Res Tech.
PubMed:
38808861

Effect of Chinese Herbal Medicine Therapy on Overall and Cancer Related Mortality in Patients With Advanced Nasopharyngeal Carcinoma in Taiwan.

Wang CY et al (2021).
Front Pharmacol.
PubMed:
33708119

Antitumor Effects and the Compatibility Mechanisms of Herb Pair Scleromitrion diffusum (Willd.) R. J. Wang-Sculellaria barbata D. Don.

Lu L et al (2020).
Front Pharmacol.
PubMed:
32265701